Skip to content

Clinical trials

Phase 3 Coronavirus Infections trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Phase 3 Country / region: Brazil Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202014
20213
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Recruiting3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE2
Eli Lilly and Company2
Pfizer2
Apsen Farmaceutica S.A.1
AstraZeneca1
Cardresearch1
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva1
Chelsea and Westminster NHS Foundation Trust1
Corvus Pharmaceuticals, Inc.1
Hospital Israelita Albert Einstein1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections21
COVID-1915
Pneumonia, Viral5
Severe Acute Respiratory Syndrome5
Lung Diseases4
Virus Diseases4
Infections3
Respiratory Tract Infections3
Pneumonia2
RNA Virus Infections2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.